Literature DB >> 12171266

Cost analysis of primary total hip replacement.

K O'Shea1, E Bale, P Murray.   

Abstract

Arthritis of the hip is a cause of significant morbidity to the sufferer, for which total hip replacement is firmly established as an effective treatment. In order to assess the cost utility and benefit of total hip replacement, we compared the costs incurred to the health benefit accrued as measured by improvement in pre to post operative Harris hip scores, WOMAC osteoarthritis indices and SF 36 scores. Our calculations suggested the average unit cost of a total hip replacement at Cappagh National Orthopaedic Hospital, in 1999, to be in the region of 6,500 pounds. Cost utility was calculated as cost per QALY. Cost benefit was expressed as cost per 10 point increments in Harris hip scores, WOMAC and SF 36 scores. We conclude that total hip replacement is a worthwhile and efficient investment of health resources.

Entities:  

Mesh:

Year:  2002        PMID: 12171266

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  8 in total

Review 1.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; N Arden; B Bannwarth; J Bijlsma; K-P Gunther; H J Hauselmann; G Herrero-Beaumont; K Jordan; P Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; B Swoboda; R Varatojo; G Verbruggen; I Zimmermann-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

2.  A historical and economic perspective on Sir John Charnley, Chas F. Thackray Limited, and the early arthoplasty industry.

Authors:  Pablo F Gomez; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2005

3.  Healthcare technology: physician collaboration in reducing the surgical cost.

Authors:  Steven A Olson; William T Obremskey; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2013-06       Impact factor: 4.176

Review 4.  The impact of non-traumatic hip and knee disorders on health-related quality of life as measured with the SF-36 or SF-12. A systematic review.

Authors:  Johanna M van der Waal; Caroline B Terwee; Daniëlle A W M van der Windt; Lex M Bouter; Joost Dekker
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

5.  Does age or bilateral disease influence the value of hip arthroplasty?

Authors:  Bryan M Lawless; Meridith Greene; James Slover; Young-Min Kwon; Henrik Malchau
Journal:  Clin Orthop Relat Res       Date:  2012-04       Impact factor: 4.176

Review 6.  The cost-effectiveness of total joint arthroplasty: a systematic review of published literature.

Authors:  Meghan E Daigle; Alexander M Weinstein; Jeffrey N Katz; Elena Losina
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-10       Impact factor: 4.098

7.  Should advanced age be a contraindication to total hip arthroplasty in femoral neck fracture patients? A matched-control, retrospective study.

Authors:  Andreas Flury; Michael Finsterwald; Dimitris Dimitriou; Naeder Helmy; Julian Hasler; Alexander Antoniadis
Journal:  J Orthop       Date:  2019-08-10

8.  Direct Inpatient Medical Costs of Operative Treatment of Periprosthetic Hip and Knee Infections Are Twofold Higher Than Those of Aseptic Revisions.

Authors:  Jie J Yao; Mario Hevesi; Sue L Visscher; Jeanine E Ransom; David G Lewallen; Daniel J Berry; Hilal Maradit Kremers
Journal:  J Bone Joint Surg Am       Date:  2021-02-17       Impact factor: 5.284

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.